Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cell Point (India)NSE:CELLPOINT +2.31%67 EV-to-EBIT is 14.63 as of Jul. 29, 2026, which is 55% above its 10-year median of 9.43. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 67/100 and a GF Value™ of ₹35.00 (Significantly Undervalued). The stock has 10 warning signs investors should review. Among 879 Retail - Cyclical companies, Cell Point (India) ranks worse than 54.15% on this metric.
The historical rank and industry rank for Cell Point (India)'s EV-to-EBIT or its related term are showing as below:
NSE:CELLPOINT'
s EV-to-EBIT Range Over the Past 10 Years
Min: 6.63 Med: 9.43 Max: 14.66
Current: 14.63
During the past 7 years, the highest EV-to-EBIT of Cell Point (India) was 14.66. The lowest was 6.63. And the median was 9.43.
NSE:CELLPOINT's EV-to-EBIT is ranked worse than 54.15% of 879
companies
in the Retail - Cyclical industry
Industry Median: 13.72
vs NSE:CELLPOINT: 14.63
Cell Point (India) (NSE:CELLPOINT) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Cell Point (India)'s Enterprise Value for the quarter that ended in Mar. 2026 was ₹936 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cell Point (India)'s EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹74 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Point (India) EV-to-EBIT Related Terms
Cell Point (India) EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Cell Point (India)'s EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CELLPOINT vs CASY, WSM, ULTA: EV-to-EBIT Comparison
For the Specialty Retail subindustry, Cell Point (India)'s EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Point (India) EV-to-EBIT vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Cell Point (India)'s EV-to-EBIT falls into.
Cell Point (India)'s current Enterprise Value is ₹1,085 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cell Point (India)'s EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹74 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Point (India) (NSE:CELLPOINT) has a EV-to-EBIT of 14.63 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cell Point (India) and its competitors. This is 55% above median its historical median of 9.43. Over the past decade, Cell Point (India)'s EV-to-EBIT has ranged from 6.63 to 14.66. According to the industry distribution chart, Cell Point (India) ranks #476 out of 879 companies in the Retail - Cyclical industry, placing it in the top 54.2%.
Is Cell Point (India)'s EV-to-EBIT too high?
Cell Point (India)'s current EV-to-EBIT of 14.63 is 55% above median its 10-year median of 9.43. Over the past 10 years, this metric has ranged from a low of 6.63 to a high of 14.66. The Retail - Cyclical industry median EV-to-EBIT is 13.72. Cell Point (India)'s value of 14.63 is 6.6% above this industry median. Based on the distribution chart, Cell Point (India) ranks #476 out of 879 companies in the Retail - Cyclical industry, which is below the industry midpoint. Overall, Cell Point (India) has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s EV-to-EBIT compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Cell Point (India) ranks #476 out of 879 companies for EV-to-EBIT. This places Cell Point (India) in the lower half of its industry. The industry median EV-to-EBIT is 13.72. Cell Point (India)'s value of 14.63 is 6.6% above this benchmark. Historically, Cell Point (India)'s own EV-to-EBIT has ranged from 6.63 to 14.66 over the past decade. While the company's 10-year median is 9.43 vs. the industry median of 13.72, Cell Point (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Retail - Cyclical company?
The median EV-to-EBIT among Retail - Cyclical companies is 13.72, based on 879 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cell Point (India)'s current EV-to-EBIT of 14.63 is 6.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cell Point (India) and its competitors. For the Retail - Cyclical industry, the median EV-to-EBIT is 13.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Point (India)'s current EV-to-EBIT is 14.63, which is 55% above median its own 10-year median of 9.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.00, compared to a current price of ₹19.95 — trading 43% below its estimated fair value. The current EV-to-EBIT is 14.63, which is 55% above median its 10-year median of 9.43 and 6.6% above the Retail - Cyclical industry median of 13.72. Cell Point (India)'s overall GF Score™ is 67/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current EV-to-EBIT is 14.63 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?
Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued.
The current stock price of ₹19.95 is trading 43% below its estimated GF Value™ of ₹35.00.
GuruFocus considers Cell Point (India) to be Significantly Undervalued.
Key valuation signals for NSE:CELLPOINT:
EV-to-EBIT: 14.63 (55% above median its 10-year median of 9.43)
GF Value™: ₹35.00 vs. price of ₹19.95 (43% below fair value)
Industry Position: 6.6% above the Retail - Cyclical median (#476 of 879)
No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
67GF Score
Get the complete analysis for NSE:CELLPOINT
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CELLPOINT has been successfully added to your 
